Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $243,635 | 24 | 57.9% |
| Consulting Fee | $71,390 | 28 | 17.0% |
| Travel and Lodging | $47,844 | 43 | 11.4% |
| Education | $45,331 | 3 | 10.8% |
| Grant | $8,553 | 2 | 2.0% |
| Food and Beverage | $3,795 | 64 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Baxter Healthcare | $323,401 | 80 | $0 (2022) |
| Pacira Pharmaceuticals Incorporated | $77,876 | 45 | $0 (2021) |
| Merck Sharp & Dohme LLC | $7,888 | 19 | $0 (2023) |
| PFIZER INC. | $3,793 | 2 | $0 (2020) |
| VERTEX PHARMACEUTICALS INCORPORATED | $3,550 | 3 | $0 (2024) |
| ACADIA Pharmaceuticals Inc | $3,088 | 4 | $0 (2022) |
| CSL Behring | $216.22 | 2 | $0 (2019) |
| Eagle Pharmaceuticals, Inc. | $122.82 | 1 | $0 (2018) |
| Grifols USA, LLC | $117.30 | 1 | $0 (2019) |
| Covidien LP | $112.00 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $700.00 | 1 | VERTEX PHARMACEUTICALS INCORPORATED ($700.00) |
| 2023 | $7,235 | 11 | Merck Sharp & Dohme LLC ($7,235) |
| 2022 | $5,359 | 5 | Baxter Healthcare ($4,332) |
| 2021 | $24,219 | 15 | Baxter Healthcare ($21,800) |
| 2020 | $14,865 | 6 | BAXTER HEALTHCARE ($10,800) |
| 2019 | $186,145 | 43 | Baxter Healthcare ($161,881) |
| 2018 | $85,897 | 32 | BAXTER HEALTHCARE ($75,613) |
| 2017 | $96,130 | 51 | Baxter Healthcare ($48,976) |
All Payment Transactions
164 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/17/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Consulting Fee | Cash or cash equivalent | $700.00 | General |
| 09/20/2023 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $5,722.50 | General |
| 09/20/2023 | Merck Sharp & Dohme LLC | — | Travel and Lodging | Cash or cash equivalent | $150.00 | General |
| 09/14/2023 | Merck Sharp & Dohme LLC | — | Travel and Lodging | In-kind items and services | $149.38 | General |
| 09/14/2023 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $57.12 | General |
| 09/14/2023 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $49.99 | General |
| 09/14/2023 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $34.99 | General |
| 09/13/2023 | Merck Sharp & Dohme LLC | — | Travel and Lodging | In-kind items and services | $433.57 | General |
| 09/13/2023 | Merck Sharp & Dohme LLC | — | Travel and Lodging | In-kind items and services | $260.00 | General |
| 09/13/2023 | Merck Sharp & Dohme LLC | — | Travel and Lodging | In-kind items and services | $232.25 | General |
| 09/13/2023 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $124.99 | General |
| 02/08/2023 | Merck Sharp & Dohme LLC | BRIDION (Drug) | Education | In-kind items and services | $19.81 | General |
| Category: NEUROSCIENCE | ||||||
| 08/31/2022 | Baxter Healthcare | SUPRANE (Drug) | Education | Cash or cash equivalent | $932.00 | General |
| Category: Integrated Pharmacy Solutions | ||||||
| 05/12/2022 | ACACIA PHARMA INC | BYFAVO (Drug) | Food and Beverage | In-kind items and services | $77.25 | General |
| Category: Anesthesiology | ||||||
| 04/28/2022 | ACADIA Pharmaceuticals Inc | — | Consulting Fee | Cash or cash equivalent | $475.00 | General |
| 02/03/2022 | Baxter Healthcare | SUPRANE (Drug) | Consulting Fee | Cash or cash equivalent | $3,400.00 | General |
| Category: Integrated Pharmacy Solutions | ||||||
| 01/24/2022 | ACADIA Pharmaceuticals Inc | — | Consulting Fee | Cash or cash equivalent | $475.00 | General |
| 12/16/2021 | Baudax Bio Inc. | ANJESO (Drug) | Food and Beverage | In-kind items and services | $103.26 | General |
| Category: Pain Management | ||||||
| 11/10/2021 | Pacira Pharmaceuticals Incorporated | Exparel (Drug) | Food and Beverage | In-kind items and services | $121.84 | General |
| Category: Pain Management | ||||||
| 10/12/2021 | Baxter Healthcare | SUPRANE (Drug) | Consulting Fee | Cash or cash equivalent | $3,400.00 | General |
| Category: Integrated Pharmacy Solutions | ||||||
| 09/02/2021 | ACADIA Pharmaceuticals Inc | — | Consulting Fee | Cash or cash equivalent | $950.00 | General |
| 07/16/2021 | Baxter Healthcare | SUPRANE (Drug) | Consulting Fee | Cash or cash equivalent | $2,400.00 | General |
| Category: Integrated Pharmacy Solutions | ||||||
| 07/16/2021 | Baxter Healthcare | IPS - Frozen Premix (Device), SEVOFLURANE, SUPRANE | Consulting Fee | Cash or cash equivalent | $800.00 | General |
| Category: Integrated Pharmacy Solutions | ||||||
| 07/16/2021 | Baxter Healthcare | SUPRANE (Drug) | Consulting Fee | Cash or cash equivalent | $600.00 | General |
| Category: Integrated Pharmacy Solutions | ||||||
| 07/16/2021 | Baxter Healthcare | SUPRANE (Drug) | Consulting Fee | Cash or cash equivalent | $400.00 | General |
| Category: Integrated Pharmacy Solutions | ||||||
About Dr. Girish Joshi, MD
Dr. Girish Joshi, MD is a Anesthesiology healthcare provider based in Dallas, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1730141516.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Girish Joshi, MD has received a total of $420,549 in payments from pharmaceutical and medical device companies, with $700.00 received in 2024. These payments were reported across 164 transactions from 16 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($243,635).
Practice Information
- Specialty Anesthesiology
- Location Dallas, TX
- Active Since 04/05/2006
- Last Updated 07/08/2007
- Taxonomy Code 207L00000X
- Entity Type Individual
- NPI Number 1730141516
Products in Payments
- SUPRANE (Drug) $273,979
- EXPAREL (Drug) $77,698
- Surgical Care - Suprane (Biological) $39,623
- IPS - Frozen Premix (Biological) $8,400
- IPS - Frozen Premix (Device) $1,400
- BRIDION (Drug) $645.00
- Kcentra (Biological) $216.22
- Exparel (Drug) $177.78
- Ryanodex Single Use Only - 250ml (Drug) $122.82
- Thrombate III (Biological) $117.30
- BIS (Device) $112.00
- ANJESO (Drug) $103.26
- OFIRMEV (Drug) $97.58
- IOVERA SYSTEM (Device) $84.89
- BYFAVO (Drug) $77.25
- CHANTIX (Drug) $13.25
- Ultiva (Drug) $10.94
- VRAYLAR (Drug) $10.47
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Anesthesiology Doctors in Dallas
James Mueller, M.d, M.D
Anesthesiology — Payments: $753,569
Dr. Peter Szmuk, Md, MD
Anesthesiology — Payments: $172,473
Dr. Richard Dutton, M.d, M.D
Anesthesiology — Payments: $89,445
Christina Riccio, M.d, M.D
Anesthesiology — Payments: $76,496
Dr. Michael Walsh, M.d, M.D
Anesthesiology — Payments: $65,832
Dr. Holly Barko, M.d, M.D
Anesthesiology — Payments: $65,718